Erick Turner, MD: Selective publication of positive trials on antidepressants
Interviewed and produced by Steven Greer, MD
Erick Turner, MD, psychiatrist at Oregon Health and Science University and former FDA medical officer reviewing psychotropic drugs, discusses his new England Journal of Medicine paper on the problem of selectively publishing only the positive trials on antidepressants and the failure of drug companies to publish the negative trials, thus skewing the body of literature.
Biostatistics, NEJM, Oregon H&S Univ, Psychiatry | apples49 | 
November 7, 2014 6:50 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
